Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shazia Afridi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 17, 2017
Migraine with prolonged aura: phenotype and treatmentMichele Viana, Shazia Afridi
Current Treatment Options in Neurology|October 1, 2003
Prophylactic Therapy for MigraineShazia Afridi, Holger Kaube
Journal of Neurology|April 15, 2004
Verapamil and lymphomatoid papulosis in chronic cluster headacheShazia Afridi, Chris M Bacon, Jonathan Bowling, et al.
SAGE Open Medicine|August 25, 2022
Reliability of functional outcome measures in adults with neurofibromatosis 2Rebecca Louise Mullin, Rebecca Smith, Susan Wood, et al.
Developmental Medicine and Child Neurology|May 22, 2018
Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern?Karine Lascelles, Shazia Afridi, Ata Siddiqui, et al.
Practical Neurology|December 11, 2019
Pelvic plexiform neurofibromatosis presenting with genital numbnessLap Yan Leung, Sachit Shah, Jai Seth, et al.
Cancer Genetics|June 9, 2021
Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHDProdromos Chatzikyriakou, Philip Touska, Mufaddal T Moonim, et al.
BMJ Open|October 17, 2020
Management of chronic headache with referral from primary care to direct access to MRI compared with Neurology services: an observational prospective study in LondonTiago Rua, Asif Mazumder, Yvonne Akande, et al.
European Journal of Pain (London, England)|June 26, 2021
Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi surveyPatricia Pozo-Rosich, Raquel Gil-Gouveia, Anne Donnet, et al.
Neuro-Oncology Practice|April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluationKatrina A Morris, John F Golding, Patrick R Axon, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 17, 2017
Migraine with prolonged aura: phenotype and treatmentMichele Viana, Shazia Afridi
Current Treatment Options in Neurology|October 1, 2003
Prophylactic Therapy for MigraineShazia Afridi, Holger Kaube
Journal of Neurology|April 15, 2004
Verapamil and lymphomatoid papulosis in chronic cluster headacheShazia Afridi, Chris M Bacon, Jonathan Bowling, et al.
SAGE Open Medicine|August 25, 2022
Reliability of functional outcome measures in adults with neurofibromatosis 2Rebecca Louise Mullin, Rebecca Smith, Susan Wood, et al.
Developmental Medicine and Child Neurology|May 22, 2018
Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern?Karine Lascelles, Shazia Afridi, Ata Siddiqui, et al.
Practical Neurology|December 11, 2019
Pelvic plexiform neurofibromatosis presenting with genital numbnessLap Yan Leung, Sachit Shah, Jai Seth, et al.
Cancer Genetics|June 9, 2021
Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHDProdromos Chatzikyriakou, Philip Touska, Mufaddal T Moonim, et al.
BMJ Open|October 17, 2020
Management of chronic headache with referral from primary care to direct access to MRI compared with Neurology services: an observational prospective study in LondonTiago Rua, Asif Mazumder, Yvonne Akande, et al.
European Journal of Pain (London, England)|June 26, 2021
Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi surveyPatricia Pozo-Rosich, Raquel Gil-Gouveia, Anne Donnet, et al.
Neuro-Oncology Practice|April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluationKatrina A Morris, John F Golding, Patrick R Axon, et al.
Pageof 2